Joel M Reid, PhD

  • 7477 Citations
  • 44 Scopus h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 7477 Citations
  • 44 Scopus h-Index
  • 171 Article
  • 1 Comment/debate
Filter
Article
1989

Liquid chromatographic determination of cyclophosphamide enantiomers in plasma by precolumn chiral derivatization

Reid, J. M., Stobaugh, J. F. & Sternson, L. A., 1989, In : Analytical Chemistry. 61, 5, p. 441-446 6 p.

Research output: Contribution to journalArticle

20 Scopus citations
1990

Plasma pharmacokinetics and cerebrospinal fluid concentrations of idarubicin and idarubicinol in pediatric leukemia patients: A Childrens Cancer Study Group report

Reid, J. M., Pendergrass, T. W., Krailo, M. D., Hammond, G. D. & Ames, M. M., Oct 15 1990, In : Cancer Research. 50, 20, p. 6525-6528 4 p.

Research output: Contribution to journalArticle

97 Scopus citations
1991

Differences in N-acetylation of the experimental antitumor agent batracylin in the mouse and the rat

Ames, M. M., Mathiesen, D. A. & Reid, J. M., 1991, In : Investigational New Drugs. 9, 3, p. 219-225 7 p.

Research output: Contribution to journalArticle

13 Scopus citations
1992
96 Scopus citations

Murine pharmacokinetics and metabolism of penclomedine [3,5-dichloro-2,4- dimethoxy-6-(trichloromethyl)pyridine, NSC 338720]

Reid, J. M., Mathiesen, D. A., Benson, L. M., Kuffel, M. J. & Ames, M. M., 1992, In : Cancer Research. 52, 10, p. 2830-2834 5 p.

Research output: Contribution to journalArticle

18 Scopus citations
1993

Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion

Blaney, S. M., Balis, F. M., Cole, D. E., Craig, C., Reid, J. M., Ames, M. M., Krailo, M., Reaman, G., Hammond, D. & Poplack, D. G., Mar 1 1993, In : Cancer Research. 53, 5, p. 1032-1036 5 p.

Research output: Contribution to journalArticle

95 Scopus citations

Study of in Vivo pyrazoloacridine metabolism by capillary electrophoresis using isotachophoresis preconcentration in non‐aqueous separation buffer

Benson, L. M., Tomlinson, A. J., Reid, J. M., Walker, D. L., Ames, M. M. & Naylor, S., 1993, In : Journal of High Resolution Chromatography. 16, 5, p. 324-326 3 p.

Research output: Contribution to journalArticle

55 Scopus citations

Suramin toxicity and efficacy in agnogenic myeloid metaplasia

Tefferi, A., Silverstein, M. N., Plumhoff, E. A., Reid, J. M. & Ames, M. M., 1993, In : Journal of the National Cancer Institute. 85, 18, p. 1520-1522 3 p.

Research output: Contribution to journalArticle

13 Scopus citations
1994

Phase I study of combined 2-chlorodeoxyadenosine and chlorambucil in chronic lymphoid leukemia and low-grade lymphoma

Tefferi, A., Witzig, T. E., Reid, J. M., Li, C. Y. & Ames, M. M., Mar 1994, In : Journal of Clinical Oncology. 12, 3, p. 569-574 6 p.

Research output: Contribution to journalArticle

44 Scopus citations

Preclinical pharmacology of bizelesin, a potent bifunctional analog of the DNA-binding antibiotic CC-1065

Walker, D. L., Reid, J. M. & Ames, M. M., 1994, In : Cancer Chemotherapy and Pharmacology. 34, 4, p. 317-322 6 p.

Research output: Contribution to journalArticle

34 Scopus citations

Pyrazine diazohydroxide (NSC-361456) - Phase I clinical and pharmacokinetic studies

Dhodapkar, M. V., Richardson, R. L., Reid, J. M. & Ames, M. M., Sep 1994, In : Investigational New Drugs. 12, 3, p. 207-216 10 p.

Research output: Contribution to journalArticle

5 Scopus citations
1995

Phase I trial of diaziquone (AZQ) plus GM-CSF

Hartmann, L. C., Ames, M. M., Reid, J. M. & Richardson, R. L., Jun 1995, In : Investigational New Drugs. 13, 2, p. 175-176 2 p.

Research output: Contribution to journalArticle

Preclinical pharmacology of cholera toxin

Reid, J. M., Benson, J. W., Viallet, J. & Ames, M. M., 1995, In : Cancer Chemotherapy and Pharmacology. 36, 2, p. 115-120 6 p.

Research output: Contribution to journalArticle

1 Scopus citations
1996

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group

Feig, S. A., Ames, M. M., Sather, H. N., Steinherz, L., Reid, J. M., Trigg, M., Pendergrass, T. W., Warkentin, P., Gerber, M., Leonard, M., Bleyer, W. A. & Harris, R. E., Dec 1996, In : Medical and Pediatric Oncology. 27, 6, p. 505-514 10 p.

Research output: Contribution to journalArticle

32 Scopus citations

Preclinical pharmacology of ecteinascidin 729, a marine natural product with potent antitumor activity

Reid, J. M., Walker, D. L. & Ames, M. M., 1996, In : Cancer Chemotherapy and Pharmacology. 38, 4, p. 329-334 6 p.

Research output: Contribution to journalArticle

17 Scopus citations
1997

Evaluation of continuous infusion suramin in metastatic breast cancer: Impact on plasma levels of insulin-like growth factors (IGFs) and IGF- binding proteins

Lawrence, J. B., Conover, C. A., Haddad, T. C., Ingle, J. N., Reid, J. M., Ames, M. M., Suman, V. J., Marks, R. S., Erlichman, C. & Hartmann, L. C., Oct 1997, In : Clinical Cancer Research. 3, 10, p. 1713-1720 8 p.

Research output: Contribution to journalArticle

18 Scopus citations

Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer

Reid, J. M., Stevens, D. C., Rubin, J. & Ames, M. M., Dec 1997, In : Clinical Cancer Research. 3, 12 I, p. 2393-2398 6 p.

Research output: Contribution to journalArticle

53 Scopus citations

Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor

Goldberg, R. M., Reid, J. M., Ames, M. M., Sloan, J. A., Rubin, J., Erlichman, C., Kuffel, M. J. & Fitch, T. R., Dec 1997, In : Clinical Cancer Research. 3, 12 I, p. 2363-2370 8 p.

Research output: Contribution to journalArticle

8 Scopus citations

Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer

Dhodapkar, M., Rubin, J., Reid, J. M., Burch, P. A., Pitot, H. C., Buckner, J. C., Ames, M. M. & Suman, V. J., Jul 1997, In : Clinical Cancer Research. 3, 7, p. 1093-1100 8 p.

Research output: Contribution to journalArticle

81 Scopus citations
1998

6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin

Budihardjo, I. I., Walker, D. L., Svingen, P. A., Buckwalter, C. A., Desnoyers, S., Eckdahl, S., Shah, G. M., Poirier, G. G., Reid, J. M., Ames, M. M. & Kaufmann, S. H., Jan 1998, In : Clinical Cancer Research. 4, 1, p. 117-130 14 p.

Research output: Contribution to journalArticle

41 Scopus citations

Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer

Reid, J. M., Kovach, J. S., O'Connell, M. J., Bagniewski, P. G. & Moertel, C. G., 1998, In : Cancer Chemotherapy and Pharmacology. 41, 6, p. 477-484 8 p.

Research output: Contribution to journalArticle

25 Scopus citations

Effect of Pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II

Adjei, A., Charron, M., Rowinsky, E. K., Svingen, P. A., Miller, J., Reid, J. M., Sebolt-Leopold, J., Ames, M. M. & Kaufmann, S. H., 1998, In : Clinical Cancer Research. 4, 3, p. 683-691 9 p.

Research output: Contribution to journalArticle

45 Scopus citations
20 Scopus citations

Phase I study of temozolomide in children and adolescents with recurrent solid tumors: A report from the children's cancer group

Nicholson, H. S., Krailo, M., Ames, M. M., Seibel, N. L., Reid, J. M., Liu-Mares, W., Vezina, L. G., Ettinger, A. G. & Reaman, G. H., Sep 1998, In : Journal of Clinical Oncology. 16, 9, p. 3037-3043 7 p.

Research output: Contribution to journalArticle

80 Scopus citations

Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks

Alberts, S. R., Erlichman, C., Reid, J. M., Sloan, J. A., Ames, M. M., Richardson, R. L. & Goldberg, R. M., Sep 1998, In : Clinical Cancer Research. 4, 9, p. 2111-2117 7 p.

Research output: Contribution to journalArticle

22 Scopus citations
1999

Efficacy of antineoplastons A10 and AS2-1 [1] (multiple letters)

Burzynski, S. R., Buckner, J. C., Reid, J. M. & Malkin, M., 1999, In : Mayo Clinic Proceedings. 74, 6, p. 641-642 2 p.

Research output: Contribution to journalArticle

6 Scopus citations

Limited sampling models for irinotecan pharmacokinetics

Sloan, J. A., Skaff, P. A., Reid, J. M., Pilot, H., Erlichman, C. & Schaaf, L., 1999, In : Clinical Pharmacology and Therapeutics. 65, 2, p. 197 1 p.

Research output: Contribution to journalArticle

1 Scopus citations

Metabolic activation of dacarbazine by human cytochromes P450: The role of CYP1A1, CYP1A2, and CYP2E1

Reid, J. M., Kuffel, M. J., Miller, J. K., Rios, R. & Ames, M. M., Aug 1999, In : Clinical Cancer Research. 5, 8, p. 2192-2197 6 p.

Research output: Contribution to journalArticle

97 Scopus citations

Murine pharmacokinetics of 6-aminonicotinamide (NSC 21206), a novel biochemical modulating agent

Walker, D. L., Reid, J. M., Svingen, P. A., Rios, R., Covey, J. M., Alley, M. C., Hollingshead, M. G., Budihardjo, I. I., Eckdahl, S., Boerner, S. A., Kaufmann, S. H. & Ames, M. M., Sep 15 1999, In : Biochemical Pharmacology. 58, 6, p. 1057-1066 10 p.

Research output: Contribution to journalArticle

22 Scopus citations

Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model

Berg, S. L., Reid, J. M., Godwin, K., Murry, D. J., Poplack, D. G., Balis, F. M. & Ames, M. M., Jan 1999, In : Journal of Pediatric Hematology/Oncology. 21, 1, p. 26-30 5 p.

Research output: Contribution to journalArticle

12 Scopus citations

Phase II study of antineoplastons A10 (NSC 648539) and AS2-1 (NSC 620261) in patients with recurrent glioma

Buckner, J. C., Malkin, M. G., Reed, E., Cascino, T. L., Reid, J. M., Ames, M. M., Tong, W. P. Y., Lim, S. & Figg, W. D., 1999, In : Mayo Clinic Proceedings. 74, 2, p. 137-145 9 p.

Research output: Contribution to journalArticle

29 Scopus citations

Phase I study of topotecan administered as a 21-day continuous infusion in children with recurrent solid tumors: A report from the children's cancer group

Frangoul, H., Ames, M. M., Mosher, R. B., Reid, J. M., Krailo, M. D., Seibel, N. L., Shaw, D. W. W., Steinherz, P. G., Whitlock, J. A. & Holcenberg, J. S., Dec 1999, In : Clinical Cancer Research. 5, 12, p. 3956-3962 7 p.

Research output: Contribution to journalArticle

43 Scopus citations

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors

Pitot, H. C., McElroy, E. A., Reid, J. M., Windebank, A. J., Sloan, J. A., Erlichman, C., Bagniewski, P. G., Walker, D. L., Rubin, J., Goldberg, R. M., Adjei, A. & Ames, M. M., Mar 1999, In : Clinical Cancer Research. 5, 3, p. 525-531 7 p.

Research output: Contribution to journalArticle

100 Scopus citations
2000

A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma

Rajkumar, S. V., Reid, J. M., Novotny, P. J., Safgren, S. L., Scheithauer, B. W., Johnson, S. P., Nair, S., Morton, R. F., Hatfield, A. K., Krook, J. E., Ames, M. M. & Buckner, J. C., 2000, In : Journal of Neuro-Oncology. 49, 3, p. 255-261 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury in vivo

Mruk, J. S., Webster, M. W. I., Heras, M., Reid, J. M., Grill, D. E. & Chesebro, J. H., Jan 25 2000, In : Circulation. 101, 3, p. 324-328 5 p.

Research output: Contribution to journalArticle

22 Scopus citations

Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: Preliminary evidence of clinical activity

Adjei, A., Klein, C. E., Kastrissios, H., Goldberg, R. M., Alberts, S. R., Pitot, H. C., Sloan, J. A., Reid, J. M., Hanson, L. J., Atherton, P., Rubin, J. & Erlichman, C., Mar 2000, In : Journal of Clinical Oncology. 18, 5, p. 1116-1123 8 p.

Research output: Contribution to journalArticle

54 Scopus citations

Phase I and pharmacologic study of sequences of gemcitabine and the multitargeted antifolate agent in patients with advanced solid tumors

Adjei, A., Erlichman, C., Sloan, J. A., Reid, J. M., Pitot, H. C., Goldberg, R. M., Peethambaram, P., Atherton, P., Hanson, L. J., Alberts, S. R. & Jett, J., Apr 2000, In : Journal of Clinical Oncology. 18, 8, p. 1748-1757 10 p.

Research output: Contribution to journalArticle

116 Scopus citations

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy

Pitot, H. C., Goldberg, R. M., Reid, J. M., Sloan, J. A., Skaff, P. A., Erlichman, C., Rubin, J., Burch, P. A., Adjei, A., Alberts, S. R., Schaaf, L. J., Elfring, G. & Miller, L. L., Jun 2000, In : Clinical Cancer Research. 6, 6, p. 2236-2244 9 p.

Research output: Contribution to journalArticle

74 Scopus citations
2001

A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities

Bracho, F., Krailo, M. D., Shen, V., Bergeron, S., Davenport, V., Liu-Mares, W., Blazar, B. R., Panoskaltsis-Mortari, A., Van de Ven, C., Secola, R., Ames, M. M., Reid, J. M., Reaman, G. H. & Cairo, M. S., 2001, In : Clinical Cancer Research. 7, 1, p. 58-67 10 p.

Research output: Contribution to journalArticle

15 Scopus citations

Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide

Sloan, J. A., Atherton, P., Reid, J. M., Pitot, H. C., Erlichman, C. & Schaaf, L., 2001, In : Cancer Chemotherapy and Pharmacology. 48, 3, p. 241-249 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2′-deoxyuridine (IdUrd)

Galanis, E., Goldberg, R., Reid, J. M., Atherton, P., Sloan, J. A., Pitot, H. C., Rubin, J., Adjei, A., Burch, P., Safgren, S. L., Witzig, T. E., Ames, M. M. & Erlichman, C., 2001, In : Annals of Oncology. 12, 5, p. 701-707 7 p.

Research output: Contribution to journalArticle

4 Scopus citations
19 Scopus citations
2002

Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2

Kuffel, M. J., Schroeder, J. C., Pobst, L. J., Naylor, S., Reid, J. M., Kaufmann, S. H. & Ames, M. M., 2002, In : Molecular Pharmacology. 62, 1, p. 143-153 11 p.

Research output: Contribution to journalArticle

55 Scopus citations

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

Adjei, A., Reid, J. M., Erlichman, C., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Ruben, S., Boerner, S. A., Atherton, P., Ames, M. M. & Kaufmann, S. H., 2002, In : Investigational New Drugs. 20, 3, p. 297-304 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors

Pitot, H. C., Reid, J. M., Sloan, J. A., Ames, M. M., Adjei, A., Rubin, J., Bagniewski, P. G., Atherton, P., Rayson, D., Goldberg, R. M. & Erlichman, C., 2002, In : Clinical Cancer Research. 8, 3, p. 712-717 6 p.

Research output: Contribution to journalArticle

28 Scopus citations

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

Adjei, A., Reid, J. M., Diasio, R. B., Sloan, J. A., Smith, D. A., Rubin, J., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P., Ames, M. M. & Erlichman, C., Mar 15 2002, In : Journal of Clinical Oncology. 20, 6, p. 1683-1691 9 p.

Research output: Contribution to journalArticle

27 Scopus citations

Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed on refractory leukemia (CCG-0955): A report from the children's cancer group

Steinherz, P. G., Seibel, N. L., Ames, M. M., Avramis, V. I., Krailo, M. D., Liu-Mares, W., Reid, J. M., Safgren, S. L. & Reaman, G. H., Oct 2002, In : Leukemia and Lymphoma. 43, 10, p. 1945-1950 6 p.

Research output: Contribution to journalArticle

20 Scopus citations

Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group study 0942

Wells, R. J., Reid, J. M., Ames, M. M., Mares, W. L., Krailo, M. D., Seibel, N. L., Mosher, R., Reaman, G. H. & Wiersma, S. R., 2002, In : Journal of Pediatric Hematology/Oncology. 24, 2, p. 89-93 5 p.

Research output: Contribution to journalArticle

11 Scopus citations

Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronide

Klein, C. E., Gupta, E., Reid, J. M., Atherton, P. J., Sloan, J. A., Pitot, H. C., Ratain, M. J. & Kastrissios, H., Dec 1 2002, In : Clinical Pharmacology and Therapeutics. 72, 6, p. 638-647 10 p.

Research output: Contribution to journalArticle

51 Scopus citations

Rat and human liver cytochrome P-450 isoform metabolism of ecteinascidin 743 does not predict gender-dependent toxicity in humans

Reid, J. M., Kuffel, M. J., Ruben, S. L., Morales, J. J., Rinehart, K. L., Squillace, D. P. & Ames, M. M., Sep 2002, In : Clinical Cancer Research. 8, 9, p. 2952-2962 11 p.

Research output: Contribution to journalArticle

42 Scopus citations